Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
glutathione bromopyruvic acid adduct

glutathione bromopyruvic acid adduct 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation | Cancer & Metabolism Bromopyruvic acid is an affinity label for cysteine residues† Anticancer agent 3-bromopyruvic acid forms

Anticancer agent 3 bromopyruvic acid forms a conjugate with glutathione ScienceDirect glutathione bromopyruvic acid adduct Synthesis and anticancer activity of Pt(iv) prodrugs containing 3 bromopyruvic as an axial ligand Rewiring of mitochondrial metabolism in Figure 1 from Glutathione in Ovarian Cancer: A Double Edged Sword Semantic Scholar Glutathione Mediated Conjugation of Anticancer Drugs Encyclopedia MDPI

SKU: 47059416130 · From telecamera-cantiere.com

4.6
USD27.37 USD60.37

Pay in 4 interest-free payments of $6.84 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

It is not Wegovy

glutathione bromopyruvic acid adduct 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation | Cancer & Metabolism Bromopyruvic acid is an affinity label for cysteine residues Anticancer agent 3-bromopyruvic acid forms

Lien, E

glutathione bromopyruvic acid adduct 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation | Cancer & Metabolism Bromopyruvic acid is an affinity label for cysteine residues Anticancer agent 3-bromopyruvic acid forms

Though considered safe when administered correctly, glutathione injections may cause mild symptoms such as discomfort at the injection site or occasional dizziness

glutathione bromopyruvic acid adduct 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation | Cancer & Metabolism Bromopyruvic acid is an affinity label for cysteine residues Anticancer agent 3-bromopyruvic acid forms

Specifically, the schedule now provides for the testing of homocysteine (HCY) and methylmalonic acid (MMA) levels in the context of B12 deficiency investigation

glutathione bromopyruvic acid adduct 3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation | Cancer & Metabolism Bromopyruvic acid is an affinity label for cysteine residues Anticancer agent 3-bromopyruvic acid forms
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products